Is DexCom (DXCM) A Good Stock To Buy?
Brown Capital Management Mid Company Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 16.55% (inst. class) for the quarter, underperforming its benchmark, the Russell Midcap Growth Index which returned 19.02% in the same quarter. You should check out Brown Capital Management’s top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021.
In the Q4 2020 Investor Letter, the fund highlighted a few stocks and Dexcom Inc (NASDAQ:DXCM) is one of them. Dexcom Inc (NASDAQ:DXCM) is a company that develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management. In the last three months, Dexcom Inc (NASDAQ:DXCM) stock gained 13.6% and on March 2nd it had a closing price of $391.91. Here is what the fund said: